Literature DB >> 35438522

Lost2PrEP: Understanding Reasons for Pre-Exposure Prophylaxis and Sexual Health Care Disengagement Among Men Who Have Sex with Men Attending a Sexual Health Clinic at a Large Urban Academic Medical Center in New York City.

Kelly Rowe1, Deborah A Theodore1, Jason Zucker1, Omid Cohensedgh2, Elijah LaSota1, Caroline Carnevale3, Alwyn Cohall4, Susan Olender1, Peter Gordon1, Magdalena E Sobieszczyk1.   

Abstract

Pre-exposure prophylaxis (PrEP) prevents HIV, but low rates of retention in care limit its effectiveness. We conducted a prospective survey-based study to investigate reasons for PrEP disengagement among men who have sex with men attending a sexual health clinic at a large urban academic medical center in New York City who were lost to follow up; surveys asked about current PrEP status, reasons for disengagement, attitudes toward PrEP, substance use, sexual practices, and behavioral/social determinants of health. Outreach attempts were made to 634 patients; majority of eligible participants were unable to be contacted (59%). Among those who agreed to participate (n = 175), 21% asked to re-establish care. Among those who completed the questionnaire (n = 86), 36% were taking PrEP. The most common reasons for PrEP discontinuation were cost/lack of insurance coverage (31%), decreased HIV risk perception (29%), and side effects (16%). Among those with decreased perception of risk, 62% were less sexually active, 38% were no longer engaging in anal sex, and 31% were using condoms for prevention. Participants reported that free medication (60%), having a sexual partner recommend PrEP (13%), and being able to receive PrEP from a primary care provider (13%) would encourage restarting PrEP. Findings were limited by low response rate (12% of eligible subjects completed the survey) and lack of Spanish-language questionnaires. Understanding reasons for loss-to-PrEP follow-up is essential for HIV prevention. Many people lost to follow up still desired PrEP, underscoring the importance of outreach, benefits navigators, and expansion of PrEP into primary care settings.

Entities:  

Keywords:  MSM; engagement in care; pre-exposure prophylaxis; sexual health

Mesh:

Substances:

Year:  2022        PMID: 35438522      PMCID: PMC9057871          DOI: 10.1089/apc.2022.0004

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.944


  22 in total

1.  On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.

Authors:  Jean-Michel Molina; Catherine Capitant; Bruno Spire; Gilles Pialoux; Laurent Cotte; Isabelle Charreau; Cecile Tremblay; Jean-Marie Le Gall; Eric Cua; Armelle Pasquet; François Raffi; Claire Pintado; Christian Chidiac; Julie Chas; Pierre Charbonneau; Constance Delaugerre; Marie Suzan-Monti; Benedicte Loze; Julien Fonsart; Gilles Peytavin; Antoine Cheret; Julie Timsit; Gabriel Girard; Nicolas Lorente; Marie Préau; James F Rooney; Mark A Wainberg; David Thompson; Willy Rozenbaum; Veronique Doré; Lucie Marchand; Marie-Christine Simon; Nicolas Etien; Jean-Pierre Aboulker; Laurence Meyer; Jean-François Delfraissy
Journal:  N Engl J Med       Date:  2015-12-01       Impact factor: 91.245

2.  Predictors of Disengagement in Care for Individuals Receiving Pre-exposure Prophylaxis (PrEP).

Authors:  Jason Zucker; Caroline Carnevale; Paul Richards; Jacek Slowikowski; Alexander Borsa; Felix Gottlieb; Isabella Vakkur; Christel Hyden; Susan Olender; Alwyn Cohall; Peter Gordon; Magdalena E Sobieszczyk
Journal:  J Acquir Immune Defic Syndr       Date:  2019-08-01       Impact factor: 3.731

3.  Barriers and Facilitators of PrEP Adherence for Young Men and Transgender Women of Color.

Authors:  Sarah Wood; Robert Gross; Judy A Shea; José A Bauermeister; Joshua Franklin; Danielle Petsis; Meghan Swyryn; Linden Lalley-Chareczko; Helen C Koenig; Nadia Dowshen
Journal:  AIDS Behav       Date:  2019-10

4.  High Rate of Discontinuation May Diminish PrEP Coverage Among Young Men Who Have Sex with Men.

Authors:  Ethan Morgan; Daniel T Ryan; Michael E Newcomb; Brian Mustanski
Journal:  AIDS Behav       Date:  2018-11

5.  Pre-exposure Prophylaxis Uptake and Discontinuation Among Young Black Men Who Have Sex With Men in Atlanta, Georgia: A Prospective Cohort Study.

Authors:  David P Serota; Eli S Rosenberg; Patrick S Sullivan; Annie L Thorne; Charlotte-Paige M Rolle; Carlos Del Rio; Scott Cutro; Nicole Luisi; Aaron J Siegler; Travis H Sanchez; Colleen F Kelley
Journal:  Clin Infect Dis       Date:  2020-07-27       Impact factor: 9.079

6.  Patient Disengagement From an HIV Preexposure Prophylaxis Program in a Sexually Transmitted Disease Clinic.

Authors:  Julia C Dombrowski; Matthew R Golden; Lindley A Barbee; Christine M Khosropour
Journal:  Sex Transm Dis       Date:  2018-09       Impact factor: 2.830

Review 7.  Defining success with HIV pre-exposure prophylaxis: a prevention-effective adherence paradigm.

Authors:  Jessica E Haberer; David R Bangsberg; Jared M Baeten; Kathryn Curran; Florence Koechlin; K Rivet Amico; Peter Anderson; Nelly Mugo; Francois Venter; Pedro Goicochea; Carlos Caceres; Kevin O'Reilly
Journal:  AIDS       Date:  2015-07-17       Impact factor: 4.177

8.  Sociodemographic Characteristics of HIV Pre-Exposure Prophylaxis Use and Reasons for Nonuse Among Gay, Bisexual, and Other Men Who Have Sex with Men from Three US Cities.

Authors:  Krishna Kiran Kota; Gordon Mansergh; Rob Stephenson; Sabina Hirshfield; Patrick Sullivan
Journal:  AIDS Patient Care STDS       Date:  2021-04-23       Impact factor: 5.078

Review 9.  Rapid Telehealth Implementation during the COVID-19 Global Pandemic: A Rapid Review.

Authors:  Cristian Lieneck; Joseph Garvey; Courtney Collins; Danielle Graham; Corein Loving; Raven Pearson
Journal:  Healthcare (Basel)       Date:  2020-11-29

10.  Substance Use and Adherence to HIV Preexposure Prophylaxis for Men Who Have Sex with Men1.

Authors:  Martin Hoenigl; Sonia Jain; David Moore; Deborah Collins; Xiaoying Sun; Peter L Anderson; Katya Corado; Jill S Blumenthal; Eric S Daar; Joel Milam; Michael P Dubé; Sheldon Morris
Journal:  Emerg Infect Dis       Date:  2018-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.